What is quinine and pregnancy

To purchase short term access, please sign in to your Oxford Academic account above. Don't already have an Oxford Academic account? Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation.

Volume The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Box 46, Mae Sot, , Thailand. Oxford Academic. Google Scholar. Kyaw Lay Thwai. When larger amounts of quinine are consumed, it can constitute a health problem.

BfR sees potential risks in particular for pregnant women. Quinine was detected in its urine. Two months later these symptoms could no longer be observed. Quinine-containing beverages are popular thirst quenchers because of their slightly bitter taste. Larger amounts are consumed particularly in the summer months also by pregnant women. Furthermore, there are recommendations posted on the Internet expressly advising pregnant women to drink quinine-containing beverages in order to counteract nocturnal calf muscle cramp or early morning sickness.

People who are advised against taking quinine by their doctors because of specific clinical pictures like tinnitus, pre-existing damage to the optic nerve, certain types of haemolytic anaemia or oversensitivity to cinchona alkaloids should refrain from consuming quinine-containing foods.

S5 Text. Deviation from published data. Acknowledgments We thank all study participants and study teams. References 1. World Health Organization.

Guidelines for the treatment of malaria. Third edition. Geneva: World Health Organization; Artesunate: developmental toxicity in monkeys. View Article Google Scholar 3. Clark RL. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Reprod Toxicol. Artesunate: developmental toxicity and toxicokinetics in monkeys.

Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count.

Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Some pregnancy-related effects of artemether in laboratory animals. El-Dakdoky MH. Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy.

Food Chem Toxicol. In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin DHA on rat embryos.

Sensitive periods for developmental toxicity of orally administered artesunate in the rat. Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients.

Li Q, Weina PJ. Severe embryotoxicity of artemisinin derivatives in experimental animals, but possibly safe in pregnant women. View Article Google Scholar Assessment of the safety of artemisinin compounds in pregnancy.

Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ. The epidemiology of severe malaria in an area of low transmission in Thailand. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa.

Artemisinin-based combination therapy versus quinine or other combinations for treatment of uncomplicated Plasmodium falciparum malaria in the second and third trimester of pregnancy: a systematic review and meta-analysis.

Open Forum Infect Dis. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, Malar J. The contribution of malaria in pregnancy to perinatal mortality.

Burden of malaria in early pregnancy: a neglected problem? Clin Infect Dis. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.

Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study. A practical handbook on the pharmacovigilance of antimalarial medicines.

Meta-analysis of individual participant data: rationale, conduct, and reporting. Haynes B. Forming research questions. Clinical epidemiology: how to do clinical practice research. Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective study in western Kenya. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings.

BMC Pregnancy Childbirth. Inclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogens. Scheuerle A, Tilson H. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Saf.

Audit of antenatal screening for syphilis and HIV in migrant and refugee women on the Thai-Myanmar border: a descriptive study. Assessment of the safety of antimalarial drug use during early pregnancy: protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.

Reprod Health. Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort. Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda. Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. PLoS Med. Patterns of antimalarial drug treatment among pregnant women in Uganda. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. Antimalarial drugs in pregnancy: a review. Curr Drug saf.

Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis. Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. Conditions for bias from differential left truncation.

Taking quinine during pregnancy is not expected to cause any problems that would require extra monitoring of your baby. However, if you have been infected with malaria during your pregnancy it is likely that your doctor will wish to monitor your pregnancy more closely, to ensure that the baby is growing and developing as expected.

A side effect of treatment with quinine can be lowered blood sugar. Your doctor may therefore wish to closely monitor your blood sugar levels if you are treated with quinine during pregnancy.

We would not expect any increased risk to your baby if its father took quinine before or around the time your baby was conceived. If you have any questions regarding the information in this leaflet please discuss them with your health care provider. They can access more detailed medical and scientific information from www. Do you have 3 minutes to complete a short, quick and simple 12 question user feedback form about our bumps information leaflets? To have your say on how we can improve our website and the information we provide please visit here.

Up to 1 out of every 5 pregnancies ends in a miscarriage, and 1 in 40 babies are born with a birth defect. These are referred to as the background population risks. Most medicines used by the mother will cross the placenta and reach the baby.

Sometimes this may have beneficial effects for the baby.